Adjuvant

摘要

The invention relates to a new adjuvant and to its use in combination with an antigen.

主权项

1. A nucleic acid molecule having a nucleotide sequence selected from the group consisting of:
i. nucleotide sequences encoding a polypeptide comprising an amino acid sequence that has at least 50% sequence identity with the amino acid sequence of SEQ ID NO:1 over its entire length, ii. nucleotide sequences comprising a nucleotide sequence that has at least 50% sequence identity with the nucleotide sequence of SEQ ID NO:2 over its entire length, iii. nucleotide sequences the complementary strand of which hybridizes to a nucleic acid molecule of sequence of (i) or (ii) and iv. nucleotide sequences which differ from the nucleotide sequence of (iii) due to the degeneracy of the genetic code, wherein said nucleotide sequence is operably linked to a nucleotide sequence encoding an antigen, and wherein said nucleic acid molecule is free of a sequence encoding for a polypeptide identical to SEQ ID NO: 3 over its entire length.